New hope for cervical cancer: dual immunotherapy combo targets tumors after standard treatment fails
NCT ID NCT07186868
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 24 times
Summary
This study is for women with cervical cancer that has come back or spread and no longer responds to standard immunotherapy. It tests a new combination of two immunotherapy drugs plus chemotherapy, with or without an anti-growth drug. The goal is to see if this combo can shrink tumors or slow the cancer. About 25 women will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CERVICAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.